Prostate Cancer - San Bernardino CA (Clinical Trial # 58871)

Prostate Cancer - San Bernardino CA (Clinical Trial # 58871)


Clinical Trial 58871

share with a friend

San Bernardino, CA 92404


Summary:

This is a clinical research study of an investigational medication, EPI-7386, for patients with metastatic castrate resistant prostate cancer.  The investigational medication will be given together with enzalutamide in order to test the effectiveness of the combination of EPI-7386 and enzalutamide versus enzalutamide alone. 

Partial Criteria:

  • Have rising PSA levels
  • Be 18 years or older
  • Diagnosed with metastatic castrate resistant prostate cancer
  • Willing to complete monthly visits in clinic
  • Willing to sign an informed consent
  • Meets study participation requirements as outlined and reviewed by study doctor

If you or someone you care for is interested in participating and lives within 50 miles of the location shown, please complete the form below and click 'Submit'

Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.

Available At:

San Bernadino Urology
Dr. Franklin Chu
San Bernardino, CA 92404
View Clinic Location

 

Comments

Popular posts from this blog

Cancer patients and doctors team up to change how cancer drugs are tested | Fox News

Member Roundtable Discussion - YouTube

Extraperitoneal robot assisted laparoscopic prostatectomy with Versius system: single centre experience | Prostate Cancer and Prostatic Diseases